| Date Filed | Type | Description |
| 10/10/2023 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 19.6% stake in STAAR Surgical Company |
| 07/28/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/15/2022 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 20% stake in Oncocyte Corporation |
| 03/25/2022 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 20.7% stake in Lineage Cell Therapeutics, Inc. |
| 10/01/2021 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 18.2% stake in STAAR Surgical Company |
| 09/24/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/15/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/05/2021 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 20.3% stake in STAAR Surgical Company |
| 03/16/2021 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 21.2% stake in Lineage Cell Therapeutics, Inc. |
| 02/09/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/28/2021 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 21.5% stake in STAAR Surgical Company |
| 01/22/2021 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 21.6% stake in OncoCyte Corporation |
| 08/12/2020 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 23.6% stake in STAAR Surgical Company |
| 09/13/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/02/2019 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 19.2% stake in OncoCyte Corporation |
| 03/12/2019 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 22.4% stake in BioTime, Inc. |
| 03/12/2019 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 0% stake in Asterias Biotherapeutics, Inc. |
| 02/12/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/10/2018 |
SC 13G
| BROADWOOD PARTNERS, L.P. reports a 8.4% stake in AgeX Therapeutics, Inc. |
| 08/10/2018 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 24.8% stake in STAAR Surgical Company |
| 03/30/2018 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 21.3% stake in OncoCyte Corporation |
| 09/18/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/17/2017 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 24.6% stake in BioTime, Inc. |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 11/14/2016 |
SC 13G
| CYNOSURE INC reports a 5.6% stake in Cynosure, Inc. |
| 09/08/2016 |
SC 13D
| OncoCyte Corp reports a 13.8% stake in OncoCyte Corporation |
| 05/27/2016 |
SC 13D/A
| BROADWOOD PARTNERS LP reports a 27% stake in STAAR Surgical Company |
| 03/24/2016 |
SC 13D/A
| BROADWOOD PARTNERS LP reports a 26% stake in STAAR Surgical Company |
| 03/29/2013 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 16.3% stake in BioTime, Inc. |
| 02/19/2013 |
SC 13D/A
| BROADWOOD PARTNERS LP reports a 20.7% stake in Comarco, Inc. |
| 08/03/2012 |
SC 13D/A
| BROADWOOD PARTNERS LP reports a 35.1% stake in Comarco, Inc. |
| 05/22/2012 |
SC 13D/A
| BROADWOOD PARTNERS LP reports a 6.4% stake in Questcor Pharmaceuticals, Inc. |
| 05/21/2012 |
SC 13D/A
| BROADWOOD PARTNERS LP reports a 6.4% stake in Questcor Pharmaceuticals, Inc. |
| 12/22/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|